TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 4.549 million compared to TWD 16.782 million a year ago. Net loss was TWD 54.079 million compared to TWD 25.462 million a year ago. Basic loss per share was TWD 0.08 compared to TWD 0.04 a year ago.